{"id":"W2085346499","doi":"10.1182/blood-2013-11-531327","title":"Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":638,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"National Cancer Institute; Teva Pharmaceutical Industries","keywords":"Bendamustine; Rituximab; Medicine; CHOP; Internal medicine; Oncology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003370306,0.001148441,0.002944228,0.0003713939,0.0003894989,0.001126702,0.0009984947,0.00162514,0.006104666],"category_scores_gemma":[0.002570438,0.0006150274,0.001788873,0.0002685438,0.00114752,0.0008533566,0.0005748752,0.003169055,0.0008523323],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007318276,"about_ca_system_score_gemma":0.001151681,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000988434,"about_ca_topic_score_gemma":0.00244,"domain_scores_codex":[0.998602,0.001050133,0.00004508728,0.0001250216,0.00005601456,0.0001216624],"domain_scores_gemma":[0.998395,0.0005948827,0.000336109,0.0001419714,0.00007958637,0.0004523842],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9913824,0.002055363,0.0002527246,0.0001662936,0.0004239907,0.00001648212,0.00001683527,0.0001235976,0.0007512122,0.0000662786,0.0004858823,0.004259017],"study_design_scores_gemma":[0.9766817,0.02176781,0.0005486362,0.00001714815,0.0002530221,0.00001095427,0.000007830328,0.0001848175,0.0001057744,0.00009888788,0.0003167295,0.000006670238],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831942,0.005524673,0.0008297995,0.001432401,0.0009637779,0.00367854,0.001236556,0.0001689003,0.002971187],"genre_scores_gemma":[0.9848021,0.002046671,0.00167869,0.002876652,0.0005728669,0.003492375,0.001158006,0.00003589038,0.003336749],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006104666,"threshold_uncertainty_score":0.02042216,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03339717663584871,"score_gpt":0.3056359735912372,"score_spread":0.2722387969553885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}